Skip to content
Clinical Trials – home

ARTEMISIA VULGARIS POLLEN EXTRACT: A Comprehensive Guide for Patients

0 / 4
trials open to patients / all trials
7+
Countries

In short

This article discusses clinical trials investigating the use of Artemisia Vulgaris Pollen Extract, commonly known as mugwort pollen extract, in treating allergies. These studies aim to evaluate the effectiveness and safety of this extract in various forms of immunotherapy for patients with allergic conditions, particularly allergic rhinitis and rhinoconjunctivitis.

At a glance

Study Type
Phase II-III clinical trials
Main Conditions Studied
Moderate to severe allergic rhinitis/rhinoconjunctivitis due to various pollen types
Primary Objective
To assess efficacy and safety of immunotherapy treatments for pollen allergies
Treatment Forms
Sublingual and subcutaneous immunotherapy
Key Outcome Measures
Combined Symptom and Medication Score (CSMS), quality of life improvements
Role of Artemisia Vulgaris Extract
Used in skin prick tests for allergy diagnosis
Patient Age Range
18-65 years
Key Inclusion Criteria
Positive skin prick test, specific IgE levels, history of allergic symptoms
Safety Assessments
Monitoring of adverse events, local and systemic reactions

What is ARTEMISIA VULGARIS POLLEN EXTRACT?

ARTEMISIA VULGARIS POLLEN EXTRACT is a substance derived from the pollen of the mugwort plant (Artemisia vulgaris). This extract is used in medical settings, particularly for diagnostic purposes and potentially for treatment of certain allergic conditions. Mugwort is a common weed found in many parts of the world, and its pollen is a known allergen for some people.

Medical Uses

The primary medical use of ARTEMISIA VULGARIS POLLEN EXTRACT is in allergy testing, specifically for diagnosing mugwort pollen allergies. It is a component of skin prick tests, which are used to identify specific allergens that may be causing allergic reactions in patients.

While the extract is primarily used for diagnostic purposes, research is ongoing to explore its potential therapeutic applications, particularly in the field of allergen-specific immunotherapy. This type of therapy aims to reduce sensitivity to specific allergens over time.

How is it Administered?

ARTEMISIA VULGARIS POLLEN EXTRACT is typically administered in the following ways:

  • Skin Prick Test: A small amount of the extract is placed on the skin, usually on the forearm or back, and the skin is then pricked. This allows a tiny amount of the allergen to enter the skin. If a person is allergic, a small, itchy bump will appear at the site within about 15 minutes.
  • Solution for Topical Use: The extract is available as a solution for skin-prick tests, typically in a concentration of 30 HEP/ml (Histamine Equivalent Prick units per milliliter).

Current Clinical Trials

While the provided clinical trial information doesn't specifically focus on ARTEMISIA VULGARIS POLLEN EXTRACT, it's worth noting that this extract is often used in allergy research alongside other common allergens. The trials mentioned are investigating treatments for various pollen allergies, which could potentially inform future research on mugwort pollen allergy treatments.

Potential Side Effects and Precautions

As with any medical procedure or substance, there are potential risks and side effects to be aware of:

  • Allergic Reactions: In rare cases, severe allergic reactions (anaphylaxis) can occur during skin prick tests. This is why these tests are always performed under medical supervision.
  • Skin Irritation: Some people may experience temporary itching, redness, or swelling at the test site.
  • False Positives/Negatives: As with any diagnostic test, there is a possibility of false positive or false negative results.

It's important to inform your healthcare provider of any medications you're taking, as some can interfere with the test results. Additionally, people with certain skin conditions or severe allergies may not be suitable candidates for skin prick tests.

Conclusion

ARTEMISIA VULGARIS POLLEN EXTRACT plays a crucial role in diagnosing mugwort pollen allergies. While its primary use is in skin prick tests, ongoing research may uncover potential therapeutic applications in the future. As with any medical procedure, it's important to discuss the risks and benefits with your healthcare provider to determine if allergy testing with this extract is appropriate for your individual situation.

Questions people often ask

Conditions where Artemisia Vulgaris Pollen Extract is being studied

Each condition opens its own overview and trial list

Trials with Artemisia Vulgaris Pollen Extract

Recruiting trials first

See all 4 →
Quick filters
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.